Related Experiment Videos
Pharmacologic prophylaxis of supraventricular tachyarrhythmias after coronary artery bypass
1Department of Pharmacy Services, Toronto Hospital-Western Division, Ontario, Canada.
Pharmacotherapy
|July 1, 1996
Insights
Coronary artery bypass surgery can lead to supraventricular arrhythmias. Prophylactic medications like calcium channel blockers, digoxin, and beta-blockers are advised to prevent these arrhythmias during the perioperative period.
Area of Science:
- Cardiology
- Cardiac Surgery
- Pharmacology
Background:
- Coronary artery disease (CAD) is a significant health concern.
- Coronary artery bypass surgery (CABS) is a standard treatment for CAD.
- Supraventricular arrhythmias (SVAs) are a common perioperative complication following CABS.
Purpose of the Study:
- To review the prophylactic administration of medications for preventing SVAs after CABS.
- To discuss the role of calcium channel blockers, digoxin, and beta-blockers in perioperative SVA prevention.
Main Methods:
- Literature review of studies on perioperative SVA prevention in CABS patients.
- Analysis of evidence supporting the use of specific drug classes.
Main Results:
- Prophylactic drug administration is a recommended strategy.
- Calcium channel blockers, digoxin, and beta-blockers have shown efficacy in reducing SVA incidence.
Conclusions:
- Pharmacological prophylaxis is a key component in managing patients undergoing CABS.
- Optimizing perioperative care through medication can improve patient outcomes and reduce morbidity.
Abstract:
Coronary artery bypass surgery is an accepted treatment for patients with coronary artery disease. Perioperative morbidity includes development of supraventricular arrhythmias. To prevent this, prophylactic administration of drugs such as calcium channel blockers, digoxin, and beta-blockers have been advised.